Related Experiment Videos

[Therapy of diabetic nephropathy]

István Barna1

  • 1Semmelweis Egyetem, Altalános Orvostudományi Kar, I. Sz. Belgyógyászati Klinika, Budapest.

Orvosi Hetilap
|March 8, 2003
PubMed

Insights

Achieving target blood pressure significantly reduces risks for diabetic patients with hypertension and nephropathy. Optimal treatment involves ACE inhibitors, AT1 receptor blockers, and comprehensive management of related conditions.

Area of Science:

  • Nephrology
  • Cardiology
  • Endocrinology

Context:

  • Diabetes mellitus is a leading cause of end-stage renal disease (ESRD) and cardiovascular complications.
  • Hypertension is a major modifiable risk factor in diabetic nephropathy progression.
  • International guidelines recommend strict blood pressure targets for diabetic patients.

Purpose:

  • To outline evidence-based strategies for blood pressure management in diabetic hypertension and nephropathy.
  • To highlight the role of specific antihypertensive agents in nephroprotection.
  • To emphasize the importance of multidisciplinary care in managing diabetic kidney disease.

Summary:

  • Target blood pressure of 130/85 mmHg for diabetes hypertension and 125/75 mmHg for diabetic nephropathy is crucial for reducing ESRD and cardiovascular events.
  • Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (AT1) are primary agents for nephroprotection and blood pressure control.
  • Combination therapy is often necessary. Comprehensive management includes glucose control, dietary modifications, and preparation for renal replacement therapy.

Impact:

  • Effective blood pressure control can significantly decrease the incidence of end-stage nephropathy and cardiovascular mortality in diabetic patients.
  • Nephroprotective strategies, particularly ACE inhibitors and AT1 blockers, are vital for preserving kidney function.
  • Coordinated care among nephrologists, diabetologists, and cardiologists is essential for slowing disease progression and improving patient outcomes.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...